Hydreight Technologies Inc. (TSXV:NURS)
Hydreight Technologies Statistics
Total Valuation
TSXV:NURS has a market cap or net worth of CAD 234.46 million. The enterprise value is 229.11 million.
| Market Cap | 234.46M |
| Enterprise Value | 229.11M |
Important Dates
The next estimated earnings date is Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:NURS has 47.27 million shares outstanding. The number of shares has increased by 9.85% in one year.
| Current Share Class | 47.27M |
| Shares Outstanding | 47.27M |
| Shares Change (YoY) | +9.85% |
| Shares Change (QoQ) | +9.86% |
| Owned by Insiders (%) | 3.28% |
| Owned by Institutions (%) | 1.10% |
| Float | 20.39M |
Valuation Ratios
The trailing PE ratio is 166,402.20 and the forward PE ratio is 23.62.
| PE Ratio | 166,402.20 |
| Forward PE | 23.62 |
| PS Ratio | 12.68 |
| PB Ratio | 68.69 |
| P/TBV Ratio | 163.38 |
| P/FCF Ratio | 206.29 |
| P/OCF Ratio | 205.93 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 162,602.17 |
| EV / Sales | 12.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 201.58 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.49 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 4.21 |
| Debt / FCF | 0.66 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.18% and return on invested capital (ROIC) is -7.44%.
| Return on Equity (ROE) | 0.18% |
| Return on Assets (ROA) | -1.54% |
| Return on Invested Capital (ROIC) | -7.44% |
| Return on Capital Employed (ROCE) | -3.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 3.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +942.55% in the last 52 weeks. The beta is 0.60, so TSXV:NURS's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +942.55% |
| 50-Day Moving Average | 3.94 |
| 200-Day Moving Average | 2.34 |
| Relative Strength Index (RSI) | 64.88 |
| Average Volume (20 Days) | 138,107 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:NURS had revenue of CAD 18.48 million and earned 1,409 in profits. Earnings per share was 0.00.
| Revenue | 18.48M |
| Gross Profit | 6.34M |
| Operating Income | -139,904 |
| Pretax Income | 1,409 |
| Net Income | 1,409 |
| EBITDA | 178,176 |
| EBIT | -139,904 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 6.10 million in cash and 749,879 in debt, giving a net cash position of 5.35 million or 0.11 per share.
| Cash & Cash Equivalents | 6.10M |
| Total Debt | 749,879 |
| Net Cash | 5.35M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 3.41M |
| Book Value Per Share | 0.08 |
| Working Capital | 2.19M |
Cash Flow
In the last 12 months, operating cash flow was 1.14 million and capital expenditures -1,995, giving a free cash flow of 1.14 million.
| Operating Cash Flow | 1.14M |
| Capital Expenditures | -1,995 |
| Free Cash Flow | 1.14M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 34.30%, with operating and profit margins of -0.76% and 0.01%.
| Gross Margin | 34.30% |
| Operating Margin | -0.76% |
| Pretax Margin | 0.01% |
| Profit Margin | 0.01% |
| EBITDA Margin | 0.96% |
| EBIT Margin | -0.76% |
| FCF Margin | 6.15% |
Dividends & Yields
TSXV:NURS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.85% |
| Shareholder Yield | -9.85% |
| Earnings Yield | 0.00% |
| FCF Yield | 0.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.
| Last Split Date | Nov 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1546061 |
Scores
TSXV:NURS has an Altman Z-Score of 6.37 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.37 |
| Piotroski F-Score | 4 |